Rating:- 50
Issue Open: | Dec 16, 2021 – Dec 20, 2021 | |||
Anchor: | Dec 15, 2021 | |||
Issue Type: | Book Built Issue | |||
Face Value: | Rs. 2 Per Equity Share | |||
Equity Shares After Issue | 8,04,82,800 Equity Share | |||
Market Cap Upper Issue Price | Rs. 2205.023 Cr. | |||
Issue Size: | Fresh Rs. 200.00 Cr OFS Rs. 500.00 Cr | |||
Issue Size: | Rs. 700.00 Cr | |||
QIB: | 75% | |||
NII: | 15% | |||
Retail: | 10% | |||
Issue Price: | Rs. 265 - 274 Per Equity Share | |||
Market Lot: | 54 (14,796) | |||
Listing At: | BSE , NSE | |||
Registrar: | www.linkintime.co.in | |||
Company Website: | www.supriyalifescience.com | |||
Retail Applications For One Time: | 47,310 | |||
Grey Market: | 1. Premium | 100 - 125 |
||
2. Kostak Price | 200 - 250 |
|||
3. Sub. 2 Kostak | 6000 - 7000 |
|||
Timetabel: | Allotment | Dec 23, 2021 | ||
Unblocking | Dec 24, 2021 | |||
Listing | Dec 28, 2021 | |||
Last Day Subscription Detail NSE + BSE | ||||
QIB: | 32.91 |
|||
NII: | 166.69 |
|||
Retail: | 57.91 |
|||
Total: | 73.94 |
|||
Applications Approx : | 23,65,514 |
|||
No. of Applicant wise: | 50x |
No comments:
Post a Comment